Folate‐decorated arginine‐based poly(ester urea urethane) nanoparticles as carriers for gambogic acid and effect on cancer cells
- 31 October 2016
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 105 (2) , 475-490
Abstract
Gambogic acid (GA) exhibits a broad spectrum of anticancer activity and low chemotoxicity to normal tissues. However, poor aqueous solubility and sensitivity to hydrolysis make its pharmaceutical applications a challenge. Linear and branched Arg‐based poly(ester urea urethane)s (Arg‐PEUUs), folate (FA)‐conjugated Arg PEUUs (FA‐Arg‐PEUUs), and their self‐assembled nanoparticles (NPs) were designed, synthesized, and studied as the potential GA carriers for cancer treatment. The average diameters of linear or branched Arg‐PEUU/FA‐Arg‐PEUU NPs were 98–267 nm. FA‐Arg‐PEUU NPs adhered onto and were internalized into HeLa and A549 cells, and showed no cytotoxicity. The GA loading efficiency in the NP carriers ranged from 40 to 98%, depending on the feed weight ratio of GA to Arg‐PEUU and the Arg‐PEUU polymer structure (i.e., linear vs. branched). The GA at 2 µg/mL concentration delivered by the FA‐Arg‐PEUU NP carriers had higher cytotoxicity and induced a higher apoptosis percentage against folate receptor (FR)‐overexpressed HeLa or HCT116 than Arg‐PEUU NPs. When compared to the free GA treatment, the GA loaded in the FA‐Arg‐PEUU NP carriers also led to significant loss of the mitochondrial membrane potential in a higher percentage of the cancer cell population and more DNA fragmentation. The GA loaded in FA‐Arg‐PEUU NP carriers at as low as 0.6 µg/mL GA concentration led to lower MMP‐2 and MMP‐9 activity of cancer cells compared to free GA, suggesting that GA‐loaded Arg‐PEUU NPs may have greater potential to reduce cancer cell invasion and metastasis than free GA. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 475–490, 2017.Keywords
This publication has 44 references indexed in Scilit:
- Synthesis and characterization of a new family of cationic amino acid‐based poly(ester amide)s and their biological propertiesJournal of Applied Polymer Science, 2011
- Use of Gel Zymography to Examine Matrix Metalloproteinase (Gelatinase) Expression in Brain Tissue or in Primary Glial Cultures2011
- Synthesis, characterization and biodegradation of functionalized amino acid-based poly(ester amide)sBiomaterials, 2010
- Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristicsJournal of Controlled Release, 2010
- Synthesis and Characterization of Biodegradable Poly(ester amide)s with Pendant Amine Functional Groups and In Vitro Cellular ResponseBiomacromolecules, 2009
- Biodegradable arginine-based poly(ester-amide)s as non-viral gene delivery reagentsBiomaterials, 2008
- Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteinsMolecular Cancer Therapeutics, 2008
- Gambogic Acid Inhibits Angiogenesis and Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2 SignalingCancer Research, 2008
- Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathwayBlood, 2007
- The folate receptor: What does it promise in tissue-targeted therapeutics?Cancer and Metastasis Reviews, 2007